iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy
This article is categorized under:
Cancer> Stem Cells and Development
Source: Wiley Interdisciplinary Reviews: Systems Biology and Medicine - Category: Biomedical Science Authors: Paola Rispoli,
Tatiana Scandiuzzi Piovesan,
Giuliana Decorti,
Gabriele Stocco,
Marianna Lucaf ò Tags: Advanced Review Source Type: research
More News: Biology | Biomedical Science | Cancer | Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Employment | Genetics | Medical Ethics | Pediatrics | PET Scan | Stem Cell Therapy | Stem Cells | Study | Toxicology